solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosin
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Lower Urinary Tract Symptoms
Conditions
Lower Urinary Tract Symptoms, Bladder Outlet Obstruction
Trial Timeline
Jun 1, 2007 → Aug 1, 2008
NCT ID
NCT00507455About solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosin
solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosin is a phase 2 stage product being developed by Astellas Pharma for Lower Urinary Tract Symptoms. The current trial status is completed. This product is registered under clinical trial identifier NCT00507455. Target conditions include Lower Urinary Tract Symptoms, Bladder Outlet Obstruction.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00507455 | Phase 2 | Completed |
Competing Products
20 competing products in Lower Urinary Tract Symptoms